Uranium Royalty Corp (UROY) concluded trading on Thursday at a closing price of $2.62, with 4.71 million shares of worth about $12.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 16.96% during that period and on July 17, 2025 the price saw a gain of about 2.34%. Currently the company’s common shares owned by public are about 133.64M shares, out of which, 112.58M shares are available for trading.
Stock saw a price change of 11.97% in past 5 days and over the past one month there was a price change of 3.97%. Year-to-date (YTD), UROY shares are showing a performance of -1.13% which increased to 19.63% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.43 but also hit the highest price of $3.12 during that period. The average intraday trading volume for Uranium Royalty Corp shares is 3.47 million. The stock is currently trading 7.58% above its 20-day simple moving average (SMA20), while that difference is up 15.95% for SMA50 and it goes to 15.78% higher than SMA200.
Uranium Royalty Corp (NASDAQ: UROY) currently have 133.64M outstanding shares and institutions hold larger chunk of about 20.27% of that.
The stock has a current market capitalization of $350.14M and its 3Y-monthly beta is at 1.46. It has posted earnings per share of -$0.03 in the same period. It has Quick Ratio of 20.25 while making debt-to-equity ratio of 0.00. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for UROY, volatility over the week remained 5.84% while standing at 5.16% over the month.
Analysts are in expectations that Uranium Royalty Corp (UROY) stock would likely to be making an EPS of -0.01 in the current quarter, while forecast for next quarter EPS is -0.01 and it is -0.05 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.01 which is -0.01 at the higher side of the target for the same. Stock’s fiscal year EPS is expected to rise by 191.75% while it is estimated to decrease by -291.24% in next year. EPS is likely to shrink at an annualized rate of -7.82% for next 5-years, compared to annual growth of 2.97% made by the stock over the past 5-years.